STAT

The stint that never happened? Biotech vet David Hung wipes Axovant from his work history

The stint that never happened? Biotech vet David Hung wipes Axovant from his work history.

A version of this story originally appeared in The Readout, STAT’s biotech newsletter. Sign up here.

Dr. has had a distinguished career in biotech, presiding over the development of a blockbuster cancer drug, is one from which he’d like to move on.

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
Genetic Variant Common Among West African Descendants Contributes To Large Cardiovascular Disease Burden
A new study in JAMA identifies a genetic variant commonly found in people of West African descent that raises a type of cardiovascular disease risk.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Sanders’ Pharma Pressure Campaign, AstraZeneca’s New ADC Factory, And More
Sen. Bernie Sanders is testing the limits of the powers of a Senate chairman with little hope of advancing his drug-pricing agenda legislatively.

Related Books & Audiobooks